Adverse events in hospice and palliative care: A pilot study to determine feasibility of collection and baseline rates

Journal of Palliative Medicine

Volumn 14, Issue 3, 2011, Pages 309-314

  Currow, David C ^a   Agar, Meera R ^a,b,c   To, Timothy H M ^d   Rowett, Debra ^d   Greene, Aine ^a   Abernethy, Amy P ^a,e  

^a FLINDERS UNIVERSITY   (Australia)

^b Braeside Hospital   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d REPATRIATION GENERAL HOSPITAL   (Australia)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; DEXAMETHASONE; DIGOXIN; FUROSEMIDE; OPIATE; VANCOMYCIN;

ADULT; AGED; ARTICLE; CONFUSION; CONSCIOUSNESS DISORDER; FALLING; FEASIBILITY STUDY; FEMALE; HOSPICE CARE; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPOGLYCEMIA; HYPOTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PILOT STUDY; SKIN MANIFESTATION; UNSPECIFIED SIDE EFFECT; URINE RETENTION;

ACCIDENTAL FALLS; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CONFUSION; FEASIBILITY STUDIES; FEMALE; HOSPICE CARE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTENSION; MALE; MIDDLE AGED; PALLIATIVE CARE; PILOT PROJECTS; RETROSPECTIVE STUDIES; URINARY RETENTION; YOUNG ADULT;

EID: 79952287384     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2010.0392     Document Type: Article

References (26)

1. Institutes of Medicine. Preventing medication errors. Washington, DC: National Academies Press, 2006.
2. Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James T: Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007;55:590-595. (Pubitemid 46496589)
3. Nicholson A, Andrew I, Etherington R, Gamlin R, Lovel T, Lloyd J: Futile and inappropriate prescribing: An assessment of the issue in a series of patients admitted to a specialist palliative care unit. Int J Pharm Pract 2001;9:R72.
4. Stevenson J, Abernethy AP, Miller C, Currow DC: Managing comorbidities in patients at the end of life. Br Med J 2004; 329:909-912. (Pubitemid 39422944)
5. Goldberg RM, Mabee J, Chan L, Wong S: Drug-drug and drug-disease interactions in the ED. Analysis of a high-risk population. Am J Emerg Med 1996;14:447-450. (Pubitemid 26272242)
6. Pavis H, Wilcock A: Prescribing of drugs for use outside their licence in palliative care: Survey of specialists in the United Kingdom. Br Med J 2001;323:484-485. (Pubitemid 32822286)
7. Regnard C, Hunter A: Increasing prescriber awareness of drug interactions in palliative care. J Pain Symptom Manage 2005;29:219-221. (Pubitemid 40386737)
8. Bernard SA, Bruera E: Drug interactions in palliative care. J Clin Oncol 2000;18:1780-1799. (Pubitemid 30220558)
9. Taylor N, Fisher S, Butler C: Benchmarking in-patient medication errors in specialist palliative care. Palliat Med 2010;24:350-351.
10. Vincent C: Understanding and responding to adverse events. N Eng J Med 2003;348:1051-1057.
11. The Joint Commission. www.jointcommission.org/NR/rdonlyres/F84F9DC6-A5DA- 490F-A91F-A9FCE26347C4/0/SE-chapter-july07.pdf. (Last accessed December 15, 2009.)
12. Brennan TA, Leape LL, Laird NM, Herbert L, Localio AR, Lawthers AG, Newhouse JP, Weiler PC, Hiatt HH: Incidence of adverse events and negligence in hospitalized patients: Results of the Harvard Medical Practice Study. Qual Saf Health Care 2004;13:145-151.
13. Walshe K: Adverse events in health care: Issues in measurement. Qual Health Care 2000;9:47-52. (Pubitemid 30148719)
14. Friedman MM: What's new in the 2004 Joint Commission Home Care and Hospice Standards 2004? Home Healthc Nurse 2004;22:56-59.
15. Holmes H, Hayley D, Alexander G, Sachs GA: Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006;166:605-608.
16. Riechelmann RP, Krzyzanowska MK, Zimmermann C: Futile medication use in terminally ill cancer patients. Support Care Cancer 2009;17:745-748.
17. Currow DC, To THM, Abernethy AP: Prescribing at times of clinical transition in chronic or progressive diseases. Int J Gerontology 2009;3:1-8.
18. Agar M, Currow D, Plummer J, Seidel R, Carnahan R, Abernethy A: Changes in anti-cholinergic load from regular prescribed medications in palliative care as death approaches. Palliat Med 2009;23(3):257-265.
19. Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM: Patterns of functional decline at the end of life. JAMA 2003;289:2387-2392. (Pubitemid 37430171)
20. Downing GM, Lesperance M, Lau F, Yang J: Survival implications of sudden functional decline as a sentinel event using the Palliative Performance Scale. J Pall Med 2010;13:2010.
21. Boyer R, McPherson ML, Deshpande G: Improving medication error reporting in hospice care. Am J Hospice Pall Med 2009;26:361-367.
22. Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA: Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a longterm care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004;2:257-264. (Pubitemid 40378780)
23. Lee J, McPherson ML: Outcomes of recommendations of hospice pharmacists. Am J Health-Syst Pharm 2006;63:2235-2239.
24. Koh NY, Koo WH: Polypharmacy in palliative care: Can it be reduced? Singapore Medical Journal 2002;43:279-283.
25. Wilcock A, Frisby TJ, Webster M, Keeley V, Finn G, Fossey K, Wee B, Beale J, Lennard MS: Potential for drug interactions involving cytochrome P450 in patient attending palliative day care centres: A multicentre audit. Br J Clin Pharmacol 2005;60:326-329. (Pubitemid 41224142)
26. Geraci J, Escalante C, Freeman J, Goodwin JS: Comorbid disease and cancer: The need for more relevant conceptual models in health service research. J Clin Oncol 2005;23:7399-7404. (Pubitemid 46291800)